{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T21:43:11Z","timestamp":1786225391198,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":204,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Aging Research &amp; Lifestyle"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jarlif.2026.100081","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:41:11Z","timestamp":1786203671000},"page":"100081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating inclusion of continuous multivariable cognitive scores for operational enrichment of preclinical Alzheimer\u2019s disease trials: a retrospective emulation study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4902-7498","authenticated-orcid":false,"given":"Henry","family":"Bayly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3118-1719","authenticated-orcid":false,"given":"Lindsay","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1690-842X","authenticated-orcid":false,"given":"Steven","family":"Lenio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Alosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2190-7608","authenticated-orcid":false,"given":"Yorghos","family":"Tripodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jarlif.2026.100081_bib0001","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jarlif.2026.100081_bib0002","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jarlif.2026.100081_bib0003","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/alzrt58","article-title":"Addressing the challenges to successful recruitment and retention in Alzheimer\u2019s disease clinical trials","volume":"2","author":"Grill","year":"2010","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jarlif.2026.100081_bib0004","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jarlif.2026.100081_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jarlif.2026.100081_bib0006","article-title":"Cognitive decline across five cognitive batteries: sample size implications for clinical trials","volume":"11","author":"Zammit","year":"2025","journal-title":"Alzheimer 19s Dement"},{"key":"10.1016\/j.jarlif.2026.100081_bib0007","article-title":"Alzheimer\u2019s disease drug development pipeline: 2025","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimer 19s Dement"},{"key":"10.1016\/j.jarlif.2026.100081_bib0008","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1474-4422(13)70194-7","article-title":"Preclinical Alzheimer\u2019s disease and its outcome: a longitudinal cohort study","volume":"12","author":"Vos","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jarlif.2026.100081_bib0009","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neurobiolaging.2017.12.018","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. Amyloid pathology in the progression to mild cognitive impairment","volume":"64","author":"Insel","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jarlif.2026.100081_bib0010","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.2017.6669","article-title":"Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons","volume":"317","author":"Donohue","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jarlif.2026.100081_bib0011","series-title":"Clinical trial registration NCT04468659","year":"2024"},{"key":"10.1016\/j.jarlif.2026.100081_bib0012","article-title":"Operationalizing selection criteria for clinical trials in Alzheimer\u2019s disease: biomarker and clinical considerations: proceedings from the Alzheimer\u2019s Association Research Roundtable (AARR) Fall 2021 meeting","volume":"11","author":"Petersen","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jarlif.2026.100081_bib0013","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of Solanezumab in preclinical Alzheimer\u2019s disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jarlif.2026.100081_bib0014","article-title":"Application of predictive models in boosting power of Alzheimer\u2019s disease clinical trials: a post hoc analysis of phase 3 solanezumab trials","volume":"8","author":"Ezzati","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jarlif.2026.100081_bib0015","doi-asserted-by":"crossref","first-page":"400","DOI":"10.14283\/jpad.2022.49","article-title":"Prediction of cognitive decline for enrichment of Alzheimer\u2019s Disease clinical trials","volume":"9","year":"2022","journal-title":"J Prev Alzheimer 19s Dis"},{"key":"10.1016\/j.jarlif.2026.100081_bib0016","doi-asserted-by":"crossref","unstructured":"Tam A, Laurent C, Colina A. de L., Dansereau C. AI-driven patient selection can drastically reduce sample sizes in Alzheimer\u2019s disease clinical trials. DOI: 10.1002\/alz70859_100413.","DOI":"10.1002\/alz70859_100413"},{"key":"10.1016\/j.jarlif.2026.100081_bib0017","article-title":"Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort","volume":"21","author":"Younes","year":"2025","journal-title":"Alzheimer 19s Dement"},{"key":"10.1016\/j.jarlif.2026.100081_bib0018","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13195-022-01105-5","article-title":"Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer\u2019s disease","volume":"14","author":"Biel","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jarlif.2026.100081_bib0019","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41746-023-00963-z","article-title":"An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials","volume":"6","author":"Oikonomou","year":"2023","journal-title":"npj Digit Med"},{"key":"10.1016\/j.jarlif.2026.100081_bib0020","series-title":"Clinical trial registration NCT05026866","article-title":"A study of Donanemab versus Placebo in participants at risk for cognitive and functional decline of Alzheimer's disease","year":"2026"},{"key":"10.1016\/j.jarlif.2026.100081_bib0021","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/WAD.0000000000000111","article-title":"Results from the NACC uniform data set neuropsychological battery crosswalk study","volume":"30","author":"Monsell","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jarlif.2026.100081_bib0022","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, pp. 785\u201394.","DOI":"10.1145\/2939672.2939785"},{"key":"10.1016\/j.jarlif.2026.100081_bib0023","unstructured":"Lundberg S, Lee S-I. A unified approach to interpreting model predictions. Epub ahead of print 25 November 2017. DOI: 10.48550\/arXiv.1705.07874."},{"key":"10.1016\/j.jarlif.2026.100081_bib0024","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-a\u03b2 protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jarlif.2026.100081_bib0025","unstructured":"Company EL and. Lilly\u2019s donanemab slowed Alzheimer\u2019s disease progression in phase 2 trial: full data presented at AD\/PD\u2122 2021 and published in NEJM, https:\/\/www.prnewswire.com\/news-releases\/lillys-donanemab-slowed-alzheimers-disease-progression-in-phase-2-trial-full-data-presented-at-adpd-2021-and-published-in-nejm-301246745.html (accessed 5 November 2025)."},{"key":"10.1016\/j.jarlif.2026.100081_bib0026","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","article-title":"The National Alzheimer\u2019s Coordinating Center (NACC) database: the uniform data set","volume":"21","author":"Beekly","year":"2007","journal-title":"Alzheimer Dis Assoc Disord"}],"container-title":["The Journal of Aging Research &amp; Lifestyle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2534773X26000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2534773X26000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T21:17:53Z","timestamp":1786223873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2534773X26000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"alternative-id":["S2534773X26000236"],"URL":"https:\/\/doi.org\/10.1016\/j.jarlif.2026.100081","relation":{},"ISSN":["2534-773X"],"issn-type":[{"value":"2534-773X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating inclusion of continuous multivariable cognitive scores for operational enrichment of preclinical Alzheimer\u2019s disease trials: a retrospective emulation study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Aging Research & Lifestyle","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jarlif.2026.100081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100081"}}